Em nossa série de artigos de destaque, analisamos publicações de relevância sobre os testes no local de prestação de cuidados de saúde (POCT), fornecendo resumos e comentários de especialistas sobre os principais aspectos do artigo e dentro do contexto mais amplo dos sistemas de POCT.
Neste artigo, abordamos a publicação abaixo, feita pelo Dr. El Osta e coautores:
Does use of point-of-care testing improve cost-effect...
Testes no local de prestação de cuidados de saúde para melhorar a relação de custo-benefício dos programas de exame de saúde nos cuidados primários
The views and opinions presented are of the author only. The content contained in this podcast is intended for informational / educational purposes only.
POCT para reduzir o risco e melhorar o gerenciamento de doenças infecciosas
Join our panel of experts from around the world to learn about Chronic disease management in the post COVID era - the value of point of care testing for cardiovascular risk and kidney disease management in diabetes and non diabetes patients. The webinar will analyse studies and present front line experience on the value of point of care testing told through the eyes of internationally acclaimed health care professionals and academics from Ge...
Manejo de doenças crônicas na era pós-COVID - o valor do teste no local de atendimento para risco cardiovascular e manejo de doenças renais em pacient...
The World Anti-Microbial Resistance (AMR) congress is the world’s largest AMR congress, with ~800 attendees from across ~50 countries and more than 250 speakers. This year, on 8–9 October 2020, myPOCacademy hosted a live seminar led by Professor Jonathan Cooke from Imperial College London and the University of Manchester (UK), now exclusively available to watch in full here.
Ouça como os testes no local de atendimento podem ajudar a reduzir a resistência antimicrobiana durante a pandemia de COVID-19
Diabetes patients are more likely to experience severe complications and higher mortality if they contract COVID-19, especially those with poorly managed diabetes. [1][2][3][4][5][6][7][8][9]
Point-of-care testing for HbA1c aids in achieving improved glycemic control with just one single office visit. [11][12][13]
Despite the viral origin of COVID-19, a standard reflex by physicians is to start treatment with antibiotics since cough,...
Veja apresentações de especialistas sobre testes de diabetes no POCT e no contexto da COVID-19
Kunihiro Matsushita, Josef Coresh, Yingying Sang, John Chalmers, Caroline Fox, Eliseo Guallar, Tazeen Jafar, Simerjot K Jassal, Gijs W D Landman, Paul Muntner, Paul Roderick, Toshimi Sairenchi, Ben Schöttker, Anoop Shankar, Michael Shlipak, Marcello Tonelli, Jonathan Townend, Arjan van Zuilen, Kazumasa Yamagishi, Kentaro Yamashita, Ron Gansevoort, Mark Sarnak, David G Warnock, Mark Woodward, Johan Ärnlöv, CKD Prognosis Consortium
Estimated glomerular filtration rate and albumin-to-creatinine ratio testing for cardiovascular risk assessment
Johan Sundström, Johan Bodegard, Andreas Bollmann, Marc G Vervloet, Patrick B Mark, Avraham Karasik, Tiago Taveira-Gomes, Manuel Botana, Kåre I Birkeland, Marcus Thuresson, Levy Jäger, Manish M Sood, Gijs VanPottelbergh, Navdeep Tangri; on behalf of the CaReMe CKD Investigators
Prevalence, outcomes and cost of chronic kidney disease
Alessandro Gasparini, Marie Evans, Josef Coresh, Morgan E Grams, Olof Norin, Abdul R Qureshi, Björn Runesson, Peter Barany, Johan Ärnlöv, Tomas Jernberg, Björn Wettermark, Carl G Elinder, Juan-Jesüs Carrero
Albuminuria testing in diabetic patients and chronic kidney disease
Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1.
Should you screen for kidney damage? What do the guidelines say?
Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1.
Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1.
Impact of ACR POC testing on the diagnosis and management of diabetic kidney disease
Gain the latest insights on respiratory infections and related rapid tests aimed at expediting appropriate isolation decisions and antiviral treatments. Be informed on the technology differences in diagnostic test methods and hear use cases on testing protocols focused on efficient patient management and quality initiatives, including antimicrobial stewardship.
Respiratory Season: New Diagnostic Challenges and Strategies for Antimicrobial Stewardship
The diagnosis moment: – the role of POCT HbA1c in undiagnosed diabetes and prediabetes in plowing the progression of diabetes and improving health equ...
This webinar will discuss screening for and prevention of chronic disease in severe mental illness (SMI) patients and patients with learning disabilities (LD).
The value of POCT in SMI health checks and patients with learning disabilities for the diagnosis, management and monitoring of diabetes and cardiovasc...
In this new webinar session, Doctor Nguyen explores the impact of the implementation of rapid molecular biology tests in the emergency department and the impact on patients care management within the emergency room.
Clinical and operational impact of rapid point-of-care SARS-COV-2 detection in an emergency department
Albuminuria, commonly measured as urine albumin-to-creatinine ratio (ACR), is an under-recognized component of chronic kidney disease (CKD) definition, staging and prognosis.
Albuminuria, elevated serum creatinine and low estimated glomerular filtration rate (eGFR) are key indicators of kidney decline. However, it is unclear if these biomarkers are independent predictors of kidney disease progression in people with type 2 diabetes mellitus (T2DM).
ACR and eGFR as predictors of cardio-renal outcomes in diabetes and kidney disease
Faster and more effectivetechnology advances diagnostic testing within the walls of the central lab and indecentralized, near-patient settings. Explore the future of the lab and gain experts’insights on the broadened scope of the lab with test methods that provide qualityinformation supporting clinical needs and decision making.
The lab of the future: How COVID-19 taught us the value of transcendent laboratory service
Omicron globally became the predominant SARS-CoV-2 variant in late 2021. Some studies have suggested Omicron has a different replication pattern that could affect detection by rapid antigen tests. Reports in social media have promulgated oral swabs as a superior sample for detecting Omicron in the early stage of infection compared to nasal swabs.
Transitioning to Endemic COVID-19 Testing: Evidence-Based Assessment on Current and Future Rapid Antigen Test Detection
The implementation of LF-LAM in patients with advanced HIV disease has showed promise as a simple, inexpensive POC platform. The webinar serves to provide insight into practical implementation of LF-LAM and demonstrate the successful integration in the South African context.
The importance of LF-LAM technology in TB diagnosis among patients with advanced HIV diagnosis
The webinar was an opportunity to share the success of HIV POC EID & VL monitoring in Mozambique and Cameroon to a larger audience and allow key stakeholders to be informed on the benefits of m-PIMA as a critical tool in reaching HIV targets.
Join this global webinar for real-world case reports on new and breakthrough infections and practical strategies being implemented in the pediatric and adult settings that help facilitate optimal care and workflow in time sensitive care settings.
COVID-19 co-infections: best practices for rapid differential diagnosis in pediatrics and adults
Diabetic kidney disease, and chronic kidney disease attributed to diabetes, occurs in 20-40% of patients with diabetes. Acute kidney injury is also one of the most significant complications associated with COVID-19. Point-of-care testing for albumin-creatinine ratio is a valuable tool for monitoring at-risk patients, especially in combination with other comorbid parameters, such as HbA1c and lipids.
ACR point-of-care testing for diabetic kidney disease
One-size does not fit all across today's diverse and dynamic test settings. From antigen to molecular tests and various use cases, rapid test methods offer unique and overlapping utility, advantages, and disadvantages.
Expert perspectives on rapid point-of-care testing for respiratory infections
en
Acesse agora
By using this site, you agree with our use of cookies.
